Table 2 The distribution of the studied groups according to age and gender
From: The role of miRNA20a and miRNA320 in Iraqi patients with COVID-19: a case–control study
Characteristics of samples | Patients Total No. = 145 | Control Total No. = 145 | P-value | |
|---|---|---|---|---|
Age (year) | Mean ± SD 40.56 ± 10.19 | Mean ± SD 38.78 ± 10.57 | 0.227 NS | |
Gender No.% | Female | 70 ( 48.27%) | 69 (47.58%) | 0.999 |
Male | 75 ( 51.72%) | 76 ( 52.41) | NS | |